OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Nicole Moschny, Gudrun Hefner, R. Grohmann, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 514-514
Open Access | Times Cited: 31
Nicole Moschny, Gudrun Hefner, R. Grohmann, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 514-514
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 178
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 178
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review
Benedikt Fischer, Wayne Hall, Thiago Marques Fidalgo, et al.
Journal of Dual Diagnosis (2023) Vol. 19, Iss. 2-3, pp. 71-96
Open Access | Times Cited: 13
Benedikt Fischer, Wayne Hall, Thiago Marques Fidalgo, et al.
Journal of Dual Diagnosis (2023) Vol. 19, Iss. 2-3, pp. 71-96
Open Access | Times Cited: 13
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
Sarah Smessaert, Johan Detraux, Siska Desplenter, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 105-123
Closed Access | Times Cited: 5
Sarah Smessaert, Johan Detraux, Siska Desplenter, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 105-123
Closed Access | Times Cited: 5
Clozapine Dosage in Treatment-Refractory Schizophrenia
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Direct Effects of Antipsychotics on Potassium Channels
Wenwen Zhuang, Seo‐Yeong Mun, Won Sun Park
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151344-151344
Closed Access
Wenwen Zhuang, Seo‐Yeong Mun, Won Sun Park
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151344-151344
Closed Access
A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations
Kamalakar Surineni, Andrew B. Smith, Rachel Glein, et al.
Kansas Journal of Medicine (2025) Vol. 18, Iss. 1, pp. 21-22
Closed Access
Kamalakar Surineni, Andrew B. Smith, Rachel Glein, et al.
Kansas Journal of Medicine (2025) Vol. 18, Iss. 1, pp. 21-22
Closed Access
Ethical Implications of Psychopharmacotherapy
Hanfried Helmchen
The International Library of Bioethics (2025), pp. 385-396
Closed Access
Hanfried Helmchen
The International Library of Bioethics (2025), pp. 385-396
Closed Access
The Higher Dose‐Adjusted Clozapine Concentrations in Non‐Smokers With High CRP Levels May Be Associated With the Lower Daily Doses of Clozapine
Yuki Kikuchi
Acta Psychiatrica Scandinavica (2025)
Closed Access
Yuki Kikuchi
Acta Psychiatrica Scandinavica (2025)
Closed Access
Clozapine-induced gastrointestinal hypomotility: UK pharmacovigilance reports, 2018–2022
Robert J. Flanagan, Simon A. Handley, Charlotte James, et al.
BJPsych Open (2025) Vol. 11, Iss. 3
Open Access
Robert J. Flanagan, Simon A. Handley, Charlotte James, et al.
BJPsych Open (2025) Vol. 11, Iss. 3
Open Access
Plasma Clozapine in Treatment Refractory Schizophrenia
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review
Filippo Pennazio, Claudio Brasso, Vincenzo Villari, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2674-2674
Open Access | Times Cited: 19
Filippo Pennazio, Claudio Brasso, Vincenzo Villari, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2674-2674
Open Access | Times Cited: 19
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective
Maike Scherf‐Clavel, Pierre Baumann, X.M. Hart, et al.
Therapeutic Drug Monitoring (2023) Vol. 46, Iss. 2, pp. 143-154
Closed Access | Times Cited: 8
Maike Scherf‐Clavel, Pierre Baumann, X.M. Hart, et al.
Therapeutic Drug Monitoring (2023) Vol. 46, Iss. 2, pp. 143-154
Closed Access | Times Cited: 8
Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders
Elif Bayram Orbe, Michael E. Benros
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1382-1382
Open Access | Times Cited: 7
Elif Bayram Orbe, Michael E. Benros
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1382-1382
Open Access | Times Cited: 7
Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016
Lene Bleich, R. Grohmann, W. Greil, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 9, pp. 1117-1134
Open Access | Times Cited: 2
Lene Bleich, R. Grohmann, W. Greil, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 9, pp. 1117-1134
Open Access | Times Cited: 2
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)
Christian Knöchel, Gudrun Hefner, Thomas Stiehl, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 3, pp. 317-320
Open Access | Times Cited: 8
Christian Knöchel, Gudrun Hefner, Thomas Stiehl, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 3, pp. 317-320
Open Access | Times Cited: 8
Predictors of Long-Acting Injectable Antipsychotic Medication Use in Patients with Schizophrenia Spectrum, Bipolar, and Other Psychotic Disorders in a United States Community-based, Integrated Health System
Mubarika Alavi, Samuel J. Ridout, Catherine Lee, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Mubarika Alavi, Samuel J. Ridout, Catherine Lee, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics
Veronika Krejčí, Irena Murínová, Ondřej Slanař, et al.
Prague Medical Report (2024) Vol. 125, Iss. 2, pp. 101-129
Open Access | Times Cited: 1
Veronika Krejčí, Irena Murínová, Ondřej Slanař, et al.
Prague Medical Report (2024) Vol. 125, Iss. 2, pp. 101-129
Open Access | Times Cited: 1
The Association Between Chronic Tobacco Smoking and Brain Alterations in Schizophrenia: A Systematic Review of Magnetic Resonance Imaging Studies
Merel Koster, Lilli Mannsdörfer, Marieke van der Pluijm, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
Merel Koster, Lilli Mannsdörfer, Marieke van der Pluijm, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention
Rui Yang, Jin-Ling Wan, Chen-Qi Pi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Rui Yang, Jin-Ling Wan, Chen-Qi Pi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia
Mila Lovrić, Marina Šagud, Andrijana Ščavničar, et al.
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 305-313
Open Access | Times Cited: 3
Mila Lovrić, Marina Šagud, Andrijana Ščavničar, et al.
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 305-313
Open Access | Times Cited: 3
Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review
Alexandre González-Rodríguez, José Antonio Monreal, Mary V. Seeman
Current Pharmaceutical Design (2022) Vol. 28, Iss. 15, pp. 1282-1293
Closed Access | Times Cited: 3
Alexandre González-Rodríguez, José Antonio Monreal, Mary V. Seeman
Current Pharmaceutical Design (2022) Vol. 28, Iss. 15, pp. 1282-1293
Closed Access | Times Cited: 3
Editorial: Advances in therapeutic drug monitoring of psychiatric subjects: Analytical strategies and clinical approaches
Laura Mercolini
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
Laura Mercolini
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
The present and the future of pharmacogenetic testing with focus on the pharmacotherapy of depression
Eva Češková, Petr Šilhán
Psychiatrie pro praxi (2024) Vol. 25, Iss. 2, pp. 71-75
Closed Access
Eva Češková, Petr Šilhán
Psychiatrie pro praxi (2024) Vol. 25, Iss. 2, pp. 71-75
Closed Access
Optimization of Clozapine Treatment
I. Cánovas Olmos, Carina Ricciardi, Mauricio Mato, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access
I. Cánovas Olmos, Carina Ricciardi, Mauricio Mato, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients
Nicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Therapeutic Drug Monitoring (2024)
Open Access
Nicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Therapeutic Drug Monitoring (2024)
Open Access
